1303PD Nivolumab in previously treated patients with metastatic squamous NSCLC: results of a European single-arm, phase 2 trial (CheckMate 171) including patients aged >= 70 years and with poor performance status.
Popat, S ; Ardizzoni, A ; Ciuleanu, T ; Dols, M ; Laktionov, K ; Szilasi, M ; Califano, Raffaele ; Costa, E ; Griffiths, R ; Paz-Ares, L ... show 10 more
Popat, S
Ardizzoni, A
Ciuleanu, T
Dols, M
Laktionov, K
Szilasi, M
Califano, Raffaele
Costa, E
Griffiths, R
Paz-Ares, L
Citations
Altmetric:
Abstract
Description
Date
2017
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
1303PD Nivolumab in previously treated patients with metastatic squamous NSCLC: results of a European single-arm, phase 2 trial (CheckMate 171) including patients aged >= 70 years and with poor performance status. 2017, 28(suppl_5): Ann Oncol